Acute Coronary Syndrome and its Antithrombotic Treatment: Focus on Aspirin and Clopidogrel Resistance

E-ISSN： 1875-6212|7|2|198-208

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.7, Iss.2, 2009-04, pp. : 198-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events

By Pamukcu Burak Oflaz Huseyin Oncul Aytac Umman Berrin Mercanoglu Fehmi Ozcan Mustafa Meric Mehmet Nisanci Yilmaz

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 2, 2006-10 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention

By Barillà Francesco

Platelets, Vol. 24, Iss. 3, 2013-05 ,pp. : 183-188

Informa Healthcare

Access to resources Recommend Favorite

Significance of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Interventions

Current Vascular Pharmacology, Vol. 5, Iss. 2, 2007-04 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite

The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment

By Kalantzi Kallirroi I. Dimitriou Andromachi A. Goudevenos John A. Tselepis Alexandros D.

Platelets, Vol. 23, Iss. 2, 2012-03 ,pp. : 121-131

Informa Healthcare

Access to resources Recommend Favorite

Variability of Antithrombotic Dosing Among Veterans Presenting With Acute Coronary Syndrome

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 4, 2015-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite